Last Week’s Top Ten: Jeff Kindler in Time Magazine, Pixantrone, Solvay Rumors and ASCO Watch

April 26, 2009 at 7:47 pm EST | Tags:

Last Week's Top Ten: Jeff Kindler in Time Magazine, Pixantrone, Solvay Rumors and ASCO Watch

We’re back!!! And, it’s that time again! Time for last week’s top ten. So let’s get to it! Here’s the stories that made us all laugh, cry, gasp, lose our tempers and say “sell sell sell!!!”

10 – Layoff Rumors: GSK, Zymogenetics

9 – Cell Therapeutics, Pixantrone – Status?

8 – Pfizer’s Jeff Kindler Nominated for Time’s 100 Most Influential

7 – Solvay Sends Email to Employees, Confirms “Consultants” and Evaluation of “Strategic Options”

6 – Pixantrone: Cardiac Issues Yes or No?

5 – The 1Q Graveyard Roundup: CTIC Escapes, La Jolla’s Last Shot, Somaxon Death Inevitable

4 – Confirmed: Abbott or Sanofi Will Buy Solvay Pharma Unit; Rumor: Rothschild Preparing to Axe Solvay Reps

3 – ASCO Watch 09: Genta, Exelixis, Roche/Genentech, Cell Therapeutics

2 – Cell Therapeutics Responds to Our Pixantrone Post!

1 – Did Vatalanib Work for Patrick Swayze?

See ya tomorrow with Monday’s Job Docket!

Image from themusik

Related Posts

| Confirmed: Abbott or Sanofi Will Buy Solvay Pharma Unit; Rumor: Rothschild Preparing to Axe Solvay Reps | Last Week’s Top Ten – Pixantrone No Match for Patrick Swayze, Facet Biotech, Solvay Rumors Ongoing | Last Week’s Top Ten: Solvay Gets Ready for Buyout, Amgen Swings Axe, BiPar and that Dude from Dirty Dancing | Last Week’s Top Ten: Sequenom Screws Up, Layoff Rumors and Patrick Swayze (Again) | $6 Billion for Solvay Pharma Unit, Will Have Bids by June |


Leave a Reply

Would you like to register?